Rare disease drugs

These companies develop and sell drugs for rare conditions, mostly inherited ones, as their main business.
+0.1%
over 1 week · S&P 500 +2.6%

Key indicators

Health
50 / 100
Fragile
Solid
Price
P/E 23
Cheap
Expensive
Up over 1 year
33 of 63
Wallets over 90 days
1 / 2 buys / sells
Buys
Sells
Health and price: against the other tags.

The 65 companies

VRTX
−1.6%
UTHR
+5.2%
ALNY
+5.8%
Others
Size: weight in the tag. Color: move over the period.
See all companies
V
Vertex Pharmaceuticals
VRTX
37.7%
−1.6%
I
Insmed
INSM
7.3%
+5.9%
U
United Therapeutics
UTHR
7.0%
+5.2%
A
Alnylam Pharmaceuticals
ALNY
6.1%
+5.8%
N
Neurocrine Biosciences
NBIX
4.8%
+1.7%
B
BridgeBio Pharma
BBIO
4.3%
+5.4%
B
BioMarin Pharmaceutical
BMRN
3.1%
+2.1%
K
Krystal Biotech
KRYS
2.5%
+1.4%
R
Rhythm Pharmaceuticals
RYTM
2.2%
+2.4%
M
Mirum Pharmaceuticals
MIRM
1.7%
+0.3%
S
Scholar Rock Holding
SRRK
1.5%
−8.0%
P
PTC Therapeutics
PTCT
1.5%
−3.0%
C
Cogent Biosciences
COGT
1.4%
−9.7%
L
Liquidia
LQDA
1.4%
+29.3%
I
Ionis Pharmaceuticals
IONS
1.3%
−26.3%
T
Travere Therapeutics
TVTX
1.3%
+2.1%
A
Amylyx Pharmaceuticals
AMLX
1.1%
+2.7%
I
Disc Medicine
IRON
1.1%
+1.4%
D
Dyne Therapeutics
DYN
0.9%
−5.0%
A
ACADIA Pharmaceuticals
ACAD
0.9%
−11.7%
D
Denali Therapeutics
DNLI
0.9%
−6.6%
P
Palvella Therapeutics
PVLA
0.7%
−13.3%
B
Beam Therapeutics
BEAM
0.7%
−13.6%
M
Maze Therapeutics
MAZE
0.6%
+0.4%
S
Sarepta Therapeutics
SRPT
0.5%
−9.8%
X
Xeris Biopharma
XERS
0.5%
+9.6%
B
BioCryst Pharmaceuticals
BCRX
0.5%
−1.0%
A
Agios Pharmaceuticals
AGIO
0.5%
+7.4%
E
Eton Pharmaceuticals
ETON
0.5%
+13.2%
C
Hemab Therapeutics
COAG
0.5%
−16.6%
S
Stoke Therapeutics
STOK
0.5%
+0.5%
P
Precigen
PGEN
0.5%
+1.6%
R
Ultragenyx Pharmaceutical
RARE
0.5%
+4.2%
T
Taysha Gene Therapies
TSHA
0.4%
−5.3%
A
Avalyn Pharma
AVLN
0.4%
+3.9%
S
Savara
SVRA
0.3%
−3.9%
M
MeiraGTx Holdings
MGTX
0.3%
+2.0%
I
Immix Biopharma
IMMX
0.2%
−2.7%
Z
Zevra Therapeutics
ZVRA
0.2%
−21.7%
S
Solid Biosciences
SLDB
0.2%
+3.8%
D
Design Therapeutics
DSGN
0.2%
+2.5%
C
Capricor Therapeutics
CAPR
0.2%
+5.9%
N
Neurogene
NGNE
0.1%
−5.5%
M
Monopar Therapeutics
MNPR
0.1%
+0.8%
T
Tectonic Therapeutic
TECX
0.1%
+2.4%
R
Rezolute
RZLT
0.1%
−5.8%
O
Ocugen
OCGN
<0.1%
−10.5%
F
Fulcrum Therapeutics
FULC
<0.1%
+1.9%
L
Larimar Therapeutics
LRMR
<0.1%
+26.4%
R
Rocket Pharmaceuticals
RCKT
<0.1%
−3.6%
L
Lexeo Therapeutics
LXEO
<0.1%
−0.7%
A
Arcturus Therapeutics
ARCT
<0.1%
−19.2%
T
Entrada Therapeutics
TRDA
<0.1%
+4.1%
K
Korro Bio
KRRO
<0.1%
−7.7%
P
PepGen
PEPG
<0.1%
+76.5%
S
Sionna Therapeutics
SION
<0.1%
+1.5%
I
Inovio Pharmaceuticals
INO
<0.1%
+17.7%
A
Abeona Therapeutics
ABEO
<0.1%
−42.0%
S
Spruce Biosciences
SPRB
<0.1%
−7.0%
A
Aardvark Therapeutics
AARD
<0.1%
+13.7%
A
Ascendis Pharma
ASND
+7.2%
J
Jazz Pharmaceuticals
JAZZ
+2.9%
P
Pharvaris
PHVS
−3.0%
Q
uniQure
QURE
+9.7%
S
Sol-Gel Technologies
SLGL
−9.7%